戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 onas vaginalis, vaginitis or cervicitis, and male circumcision.
2  trials as well as new studies pertaining to male circumcision.
3 e most culturally-appropriate way to promote male circumcision.
4 of HIV-infected men resuming sex early after male circumcision.
5 ure prophylaxis (PrEP) and voluntary medical male circumcision.
6 unt testing would increase uptake of ART and male circumcision.
7 o generate new policy statements on neonatal male circumcision.
8  a generalized HIV epidemic and low rates of male circumcision.
9 ant decreases in condom use occurred in both male circumcision acceptors (-9.2% with all partners and
10 ption were observed in both groups (-7.8% in male circumcision acceptors and -6.1% in nonacceptors),
11 comes estimate that 3.3% (P < 0.0001) of the male circumcision acceptors reduced their engagement in
12 m use (adjIRR, 0.56 [95% CI, 0.36-0.89]) and male circumcision (adjIRR, 0.70 [95% CI, 0.55-0.91]), an
13 ged >40 years to those aged 15-19 years) and male circumcision (adjPRR = 0.60; 95% CI = 0.47-0.77) an
14 tudies have indicated a protective effect of male circumcision against acquisition of human immunodef
15 ral explanation for the protective effect of male circumcision against HIV-1.
16                              Universal adult male circumcision alone resulted in a 21% incidence redu
17                                              Male circumcision also was associated with significant r
18 vidence of risk compensation associated with male circumcision among this cohort of men during 3 year
19 great emphasis on the following: scale-up of male circumcision and early ART initiation with outreach
20 ded beyond those recommended by WHO, such as male circumcision and emergency obstetric surgery.
21  insertive anal sex, the association between male circumcision and HIV was protective but not statist
22             However, the association between male circumcision and HPV viral load remains unclear.
23 ewed the evidence for an association between male circumcision and Human Papillomavirus (HPV) infecti
24 0.69; k = 3).Neither the association between male circumcision and other STIs (odds ratio, 1.06; 95%
25 studies have reported an association between male circumcision and reduced risk of HIV infection in f
26  have also investigated associations between male circumcision and risk of acquisition of HIV and sex
27 ledge, attitudes and practices about medical male circumcision and their understandings of partial ef
28 ement HIV prevention efforts such as medical male circumcision and treatment as prevention.
29  review all evidence on associations between male circumcision and women's health outcomes to benefit
30  publications reporting associations between male circumcision and women's health outcomes up to Apri
31                            Synergies between male circumcision and women's health programmes should b
32 ntions to reduce new HIV infections, such as male circumcision, and on demand creation for early trea
33 eaders had a substantial effect on uptake of male circumcision, and should be considered as part of m
34                                Additionally, male circumcision appears to reduce penile cancer and ce
35                                              Male circumcision appears to reduce the infection of sev
36 in which multiple partnerships and a lack of male circumcision are common.
37 aran Africa and enhance the effectiveness of male circumcision as an HIV prevention strategy.
38 tention, earlier antiretroviral therapy, and male circumcision as the budget allows.
39 of behaviour change, condom use, and medical male circumcision, as well as expanded use of antiretrov
40 siting a circumcision facility and uptake of male circumcision at 3 months.
41 nd genital factors of the transmitter (i.e., male circumcision, bacterial vaginosis, and use of acycl
42  discounted more) and at older ages (because male circumcision becomes less effective).
43 ave sex with men and sex workers), including male circumcision, behavioral interventions, and chemopr
44                      Modelled interventions (male circumcision, behaviour change communication, early
45 ors and uptake of antiretroviral therapy and male circumcision between community types.
46 rn Africa, calling for 80% coverage of adult male circumcision by 2016.
47 though most providers had heard that medical male circumcision can reduce risk of HIV acquisition in
48                               Investments in male circumcision carry a financial rate of return of up
49  62 (28%) of 224 men were circumcised in the male circumcision clinic referral group compared with 13
50                                              Male circumcision could potentially reduce the risk of H
51                                              Male circumcision could provide substantial protection a
52 onfirmed, these results suggest that medical male circumcision could substantially reduce incidence o
53 posure prophylaxis, condom distribution, and male circumcision, could avert a further 150 000 new inf
54                                              Male circumcision coverage increased from 15% in 1999 to
55                                              Male circumcision decreases HIV acquisition by 60%, and
56               Contrary to findings in males, male circumcision did not affect HSV-2 acquisition among
57 hty-one percent of the men self-selected for male circumcision during the period, and their sociodemo
58 xisting interventions (promoting condom use, male circumcision, early antiretroviral therapy [ART] in
59 rican men, supports further investigation of male circumcision for HIV prevention among MSM.
60  from the PLOS Collection "Voluntary Medical Male Circumcision for HIV Prevention: Improving Quality,
61                  We assessed the efficacy of male circumcision for the prevention of herpes simplex v
62 the ages of 15 and 49 years in two trials of male circumcision for the prevention of HIV and other se
63 ondom promotion, antiretroviral therapy, and male circumcision) for key populations and the wider pop
64                                              Male circumcision had a low incidence of AEs overall, es
65 idence interval, 0.22-2.28; k=4) [corrected].Male circumcision had a protective association with HIV
66             Our aim was to determine whether male circumcision had a protective effect against HIV in
67                                              Male circumcision has become an important component of H
68            Risk compensation associated with male circumcision has been a concern for male circumcisi
69                                    A lack of male circumcision has been associated with increased ris
70                                      Medical male circumcision has been shown to reduce HIV transmiss
71                                              Male circumcision has received international attention a
72 ering combinations of male condom use, adult male circumcision, HIV testing, and early antiretroviral
73 an African countries plan to scale-up infant male circumcision (IMC) for cost-efficient HIV preventio
74         Increasing data support the value of male circumcision in geographic areas with high prevalen
75 ive methods to assess women's perceptions of male circumcision in Iringa, Tanzania.
76 g data from a randomized controlled trial of male circumcision in Kisumu, Kenya, adjusted mean surviv
77 However, the comparable protective effect of male circumcision in MSM studies conducted before the er
78  of antiretroviral therapy (ART) and medical male circumcision in Rakai, Uganda.
79 ncurrently enrolled in a randomised trial of male circumcision in Rakai, Uganda.
80 rol trials have demonstrated the efficacy of male circumcision in reducing the incidence of HIV infec
81                  INTERPRETATION: Scale-up of male circumcision in sub-Saharan Africa has public healt
82 e attesting to the effectiveness of clinical male circumcision in the prevention of HIV/AIDS transmis
83 age women about the risks and limitations of male circumcision, in addition to the benefits, should b
84 ientific, religious, and cultural aspects of male circumcision (intervention group), or standard outr
85                                              Male circumcision is a primary HIV-1 prevention interven
86                                              Male circumcision is being widely deployed as an HIV pre
87                             Condom use after male circumcision is essential for HIV prevention.
88                                The cost of a male circumcision is refinanced fastest, after 13 y, for
89                                              Male circumcision may lower men's risk of human papillom
90      A randomized trial of voluntary medical male circumcision (MC) of HIV-infected men reported incr
91     Randomized trials have demonstrated that male circumcision (MC) reduces heterosexual acquisition
92  different intervention models for promoting male circumcision (MC) to prevent HIV transmission in We
93 ort study of 221 HIV-infected men undergoing male circumcision (MC) was conducted in Rakai, Uganda.
94 rs may be at an increased risk of HSV-2 from male circumcision (MC) wounds.
95                    Approximately 1.4 million male circumcisions (MCs) are performed annually in US me
96 e estimated the 72-month efficacy of medical male circumcision (MMC) against herpes simplex virus 2 (
97                                      Medical male circumcision (MMC) and antiretroviral therapy (ART)
98 lower cost by increasing coverage of medical male circumcision (MMC) and antiretroviral treatment (AR
99 about the limited/partial protection medical male circumcision offers.
100     Our aim was to investigate the effect of male circumcision on HIV incidence in men.
101 rica demonstrating the protective effects of male circumcision on HIV infection, studies have reporte
102                    We examined the effect of male circumcision on the acquisition of 3 nonulcerative
103           All villages received the standard male circumcision outreach activities provided by the Mi
104  proximity (<60 km) and the time that a free male circumcision outreach campaign from the Tanzanian M
105 sk factors (partner plasma viral load, STIs, male circumcision, pregnancy) were integrated with the S
106 line of providers' understandings of medical male circumcision prior to roll-out, and can be used to
107 mcision, and should be considered as part of male circumcision programmes in other sub-Saharan Africa
108                     In South Africa, medical male circumcision programs were rolled-out in 2010.
109 y evidence was found for five outcomes, with male circumcision protecting against cervical cancer, ce
110    Medium-consistency evidence was found for male circumcision protecting against human papillomaviru
111 s of MSM revealed insufficient evidence that male circumcision protects against HIV infection or othe
112 n men participating in a randomized trial of male circumcision provided exfoliated penile cells from
113                  Less is known about whether male circumcision provides protection against HIV infect
114 tructural strategies have made a difference--male circumcision provides substantial protection from s
115                                              Male circumcision reduced HIV incidence in men without b
116                                              Male circumcision reduces acquisition of herpes simplex
117                          We assessed whether male circumcision reduces HSV-2 infection among female p
118                                              Male circumcision reduces human immunodeficiency virus (
119                                              Male circumcision reduces men's risk of acquiring HIV an
120 als and meta-analyses have demonstrated that male circumcision reduces men's risk of contracting huma
121                                              Male circumcision reduces the incidence of multiple HR-H
122                  Randomised trials show that male circumcision reduces the prevalence and incidence o
123                                        While male circumcision reduces the risk of female-to-male HIV
124 gical and observational studies suggest that male circumcision reduces the risk of HIV acquisition in
125 ith male circumcision has been a concern for male circumcision scale-up programs.
126 r sociodemographic factors, sexual behavior, male circumcision, sexually transmitted infections, preg
127                   Our findings indicate that male circumcision should now be accepted as an efficacio
128 o decreasing the incidence of HIV infection, male circumcision significantly reduced the incidence of
129                                              Male circumcision significantly reduced the incidence of
130                                              Male circumcision significantly reduces the risk of HIV
131 atus, herpes simplex virus 2 serostatus, and male circumcision status among HESN participants.
132 ally, syphilis serology testing was done and male circumcision status was assessed.
133 d to consider collaboration with traditional male circumcision (TMC) providers when planning for VMMC
134 es are expanding access to voluntary medical male circumcision to reduce HIV prevalence.
135                  We assessed the efficacy of male circumcision to reduce prevalence and incidence of
136 s and 209 HIV-positive couples enrolled in a male circumcision trial in Rakai, Uganda, using the Roch
137 )-negative couples followed for 2 years in a male circumcision trial in Rakai, Uganda, using the Roch
138 ial data collected during 2007-2011 on 2,137 male circumcision trial participants who were uncircumci
139      A case-control analysis nested within a male circumcision trial was conducted.
140 ive antiretroviral therapy, as in the recent male circumcision trials of heterosexual African men, su
141 nt-reported use of ART, participant-reported male circumcision, viral-load suppression, and sexual be
142 y of demand generation for voluntary medical male circumcision (VMMC) among 15-29 year-old males in Z
143  of steps for cascades for voluntary medical male circumcision (VMMC) and for partner reduction or co
144 ons show the importance of voluntary medical male circumcision (VMMC) in generalized epidemics.
145  to increase the uptake of voluntary medical male circumcision (VMMC) in sub-Saharan Africa and enhan
146                            Voluntary medical male circumcision (VMMC) is capable of reducing the risk
147 Countries participating in voluntary medical male circumcision (VMMC) scale-up have adopted most of s
148 ve towards the adoption of voluntary medical male circumcision (VMMC).
149                            The prevalence of male circumcision was 40.6%, and age-specific prevalence
150                                    Uptake of male circumcision was almost two-times higher in men who
151                                              Male circumcision was associated with a 42% reduction in
152                                              Male circumcision was associated with decreased risk of
153                   We aimed to assess whether male circumcision was associated with incident syphilis
154 ntercourse; and, in three randomised trials, male circumcision was protective against HIV acquisition
155  independent randomised controlled trials of male circumcision, we enrolled HIV-negative men and thei
156 372 males who were not randomized to receive male circumcision were enrolled.
157                       The health benefits of male circumcision were generally overstated; many respon
158                                              Male circumcision will likely play an important role in
159 sh whether educating religious leaders about male circumcision would increase uptake in their village

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top